Nuo Therapeutics Statistics
Total Valuation
AURX has a market cap or net worth of 65.56 million. The enterprise value is 65.65 million.
| Market Cap | 65.56M |
| Enterprise Value | 65.65M |
Important Dates
The next estimated earnings date is Monday, August 11, 2025.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
AURX has 46.83 million shares outstanding. The number of shares has increased by 7.92% in one year.
| Current Share Class | 46.83M |
| Shares Outstanding | 46.83M |
| Shares Change (YoY) | +7.92% |
| Shares Change (QoQ) | -0.76% |
| Owned by Insiders (%) | 47.47% |
| Owned by Institutions (%) | 2.20% |
| Float | 19.70M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 40.59 |
| PB Ratio | -307.67 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -27.81 |
| EV / Sales | 40.65 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -31.99 |
Financial Position
The company has a current ratio of 0.47
| Current Ratio | 0.47 |
| Quick Ratio | 0.26 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.07 |
| Interest Coverage | -1,275.57 |
Financial Efficiency
Return on equity (ROE) is -3,922.86% and return on invested capital (ROIC) is -653.64%.
| Return on Equity (ROE) | -3,922.86% |
| Return on Assets (ROA) | -130.45% |
| Return on Invested Capital (ROIC) | -653.64% |
| Return on Capital Employed (ROCE) | 1,859.28% |
| Revenue Per Employee | 179,442 |
| Profits Per Employee | -262,339 |
| Employee Count | 9 |
| Asset Turnover | 1.35 |
| Inventory Turnover | 2.40 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +278.38% in the last 52 weeks. The beta is -972.97, so AURX's price volatility has been lower than the market average.
| Beta (5Y) | -972.97 |
| 52-Week Price Change | +278.38% |
| 50-Day Moving Average | 1.53 |
| 200-Day Moving Average | 1.26 |
| Relative Strength Index (RSI) | 42.93 |
| Average Volume (20 Days) | 16,512 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.72 |
Income Statement
In the last 12 months, AURX had revenue of 1.61 million and -2.36 million in losses. Loss per share was -0.05.
| Revenue | 1.61M |
| Gross Profit | 1.24M |
| Operating Income | -2.49M |
| Pretax Income | -2.36M |
| Net Income | -2.36M |
| EBITDA | -2.46M |
| EBIT | -2.49M |
| Loss Per Share | -0.05 |
Balance Sheet
The company has 55,655 in cash and 148,109 in debt, giving a net cash position of -92,454 or -0.00 per share.
| Cash & Cash Equivalents | 55,655 |
| Total Debt | 148,109 |
| Net Cash | -92,454 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -213,073 |
| Book Value Per Share | -0.00 |
| Working Capital | -679,372 |
Cash Flow
In the last 12 months, operating cash flow was -1.67 million and capital expenditures -384,846, giving a free cash flow of -2.05 million.
| Operating Cash Flow | -1.67M |
| Capital Expenditures | -384,846 |
| Free Cash Flow | -2.05M |
| FCF Per Share | -0.04 |
Margins
Gross margin is 76.89%, with operating and profit margins of -154.41% and -146.20%.
| Gross Margin | 76.89% |
| Operating Margin | -154.41% |
| Pretax Margin | -146.20% |
| Profit Margin | -146.20% |
| EBITDA Margin | -152.27% |
| EBIT Margin | -154.41% |
| FCF Margin | n/a |
Dividends & Yields
AURX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.92% |
| Shareholder Yield | n/a |
| Earnings Yield | -3.60% |
| FCF Yield | -3.13% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
AURX has an Altman Z-Score of -28.65 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -28.65 |
| Piotroski F-Score | 2 |